Zobrazeno 1 - 10 of 204 pro vyhledávání: '"Lineburg, K."'
1
Akademický článek
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer.
Autor: Body A; Monash Health, Department of Oncology, Melbourne, VIC, Australia; Monash University, Department of Oncology, School of Clinical Sciences, Melbourne, VIC, Australia. Electronic address: amy.body@monash.edu., Lal L; Monash Health, Department of Oncology, Melbourne, VIC, Australia; Monash University, Department of Oncology, School of Clinical Sciences, Melbourne, VIC, Australia., Srihari S; Queensland Institute of Medical Research-Berghofer, QLD, Australia., MacIntyre CR; Biosecurity Program, Kirby Institute, University of New South Wales, Sydney, NSW, Australia; School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia; National Centre for Immunization, Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead, NSW, Australia., Buttery J; University of Melbourne, Child Health Informatics (Paediatrics), Melbourne, VIC, Australia; Royal Children's Hospital, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Parkville, VIC, Australia., Ahern ES; Monash Health, Department of Oncology, Melbourne, VIC, Australia; Monash University, Department of Oncology, School of Clinical Sciences, Melbourne, VIC, Australia., Opat S; Monash Health, Department of Oncology, Melbourne, VIC, Australia; Monash University, Department of Oncology, School of Clinical Sciences, Melbourne, VIC, Australia., Leahy MF; Department of Haematology, Royal Perth Hospital, WA, Australia; University of Western Australia, School of Medicine & Pharmacology, School of Pathology, Perth, WA, Australia., Hamad N; Department of Haematology, St Vincent's Hospital, Kinghorn Cancer Centre, Sydney, NSW, Australia; The University of New South Wales, NSW, Australia., Milch V; Cancer Australia, Sydney, NSW, Australia; Caring Futures Institute, Flinders University, Adelaide, SA, Australia; School of Medicine, The University of Notre Dame Australia, Sydney, NSW, Australia., Turville S; Kirby Institute, University of New South Wales, Sydney, NSW, Australia; University of Sydney, NSW, Australia., Smith C; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; Queensland Immunology Research Centre, Brisbane, QLD, Australia., Lineburg K; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Naing Z; Serology and Virology Division (SAViD), NSW Health Pathology East, Department of Microbiology, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia., Rawlinson W; Serology and Virology Division (SAViD), NSW Health Pathology East, Department of Microbiology, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia; Virology Research Laboratory, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., Segelov E; Monash University, Department of Oncology, School of Clinical Sciences, Melbourne, VIC, Australia; University of Bern, Department of Clinical Research (Medicine), Bern, Switzerland; University Cancer Centre, Bern, Switzerland.
Publikováno v: Vaccine [Vaccine] 2024 Dec 07, pp. 126547. Date of Electronic Publication: 2024 Dec 07.
Zobrazit plný text záznamu
2
Akademický článek
In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting.
Autor: Tu WJ; Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Melino M; Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Dunn J; Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., McCuaig RD; Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Bielefeldt-Ohmann H; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia., Tsimbalyuk S; School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia., Forwood JK; School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia., Ahuja T; Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Vandermeide J; Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Tan X; Genomics and Machine Learning Lab, Division of Genetics and Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, 4072, Australia., Tran M; Genomics and Machine Learning Lab, Division of Genetics and Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, 4072, Australia., Nguyen Q; Genomics and Machine Learning Lab, Division of Genetics and Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, 4072, Australia., Zhang L; NanoString Technologies Inc., Seattle, WA, 98109, USA., Nam A; NanoString Technologies Inc., Seattle, WA, 98109, USA., Pan L; NanoString Technologies Inc., Seattle, WA, 98109, USA., Liang Y; NanoString Technologies Inc., Seattle, WA, 98109, USA., Smith C; Translational and Human Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Lineburg K; Translational and Human Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Nguyen TH; Flow and Imaging Facility, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Sng JDJ; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia., Tong ZWM; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia., Chew KY; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia., Short KR; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.; Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, Australia., Le Grand R; Université Paris-Saclay, INSERM U1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Seddiki N; Université Paris-Saclay, INSERM U1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Rao S; Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. sudha.rao@qimrberghofer.edu.au.
Publikováno v: Nature communications [Nat Commun] 2023 Jun 27; Vol. 14 (1), pp. 3680. Date of Electronic Publication: 2023 Jun 27.
Zobrazit plný text záznamu
3
Akademický článek
1080 - Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2
Autor: Henden, A., Lineburg, K., Le Texier, L., Raju, J., Crooks, P., Wright, E., Scott, A., Neller, M.A., Tey, S., Khanna, R., Smith, C.
Publikováno v: In Cytotherapy May 2023 25(6) Supplement:S252-S252
Zobrazit plný text záznamu
4
Akademický článek
1064 - Immunotherapy: DEVELOPMENT OF NOVEL IMMUNOTHERAPEUTICS FOR EBV ASSOCIATED DISEASES IN PRECLINICAL SETTINGS
Autor: Muralidhar, S., Smith, C., Khanna, R., Lineburg, K.
Publikováno v: In Cytotherapy May 2023 25(6) Supplement:S242-S242
Zobrazit plný text záznamu
6
Akademický článek
1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer
Autor: Segelov, E. 1, Body, A. 1, Lal, L. 1, Abdulla, H. 1, Turville, S. 2, Naing, Z. 3, Opat, S. 4, Leahy, M. 5, Balendra, J.R. 5, Hamad, N. 6, Mccuaig, R. 7, Rao, S. 8, Lineburg, K. 9, Smith, C. 10, MacIntyre, C.R. 11, Milch, V. 12, Busija, L. 13, Ahern, E.S. 1
Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S1279-S1279
Zobrazit plný text záznamu
7
Akademický článek
Pre-clinical development of T-cell immunotherapy for covid-19
Autor: Smith, C. 1, Panikkar, A. 1, Raju, J. 1, Rehan, S. 1, Lineburg, K. 1, Crooks, P. 1, Ambalathingal Thomas, G. 1, Swaminathan, S. 1, Khanna, R. 1, Matthews, K. 1, Neller, M. 1
Publikováno v: In Cytotherapy May 2021 23(5) Supplement:S108-S108
Zobrazit plný text záznamu
8
Akademický článek
Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activity.
Autor: Weerakoon H; Precision and Systems Biomedicine Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia.; School of Biomedical Sciences The University of Queensland Brisbane QLD Australia.; Department of Biochemistry Faculty of Medicine and Allied Sciences Rajarata University of Sri Lanka Saliyapura Sri Lanka., Straube J; Gordon and Jessie Gilmour Leukaemia Research Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia., Lineburg K; Translational and Human Immunology Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia., Cooper L; Gordon and Jessie Gilmour Leukaemia Research Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia., Lane S; Gordon and Jessie Gilmour Leukaemia Research Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia.; School of Medicine University of Queensland Brisbane QLD Australia., Smith C; Translational and Human Immunology Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia., Alabbas S; Inflammatory Bowel Diseases Research Group Mater Research Institute University of Queensland Brisbane QLD Australia., Begun J; School of Medicine University of Queensland Brisbane QLD Australia.; Inflammatory Bowel Diseases Research Group Mater Research Institute University of Queensland Brisbane QLD Australia.; Mater Hospital Brisbane Brisbane QLD Australia., Miles JJ; Human Immunity Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia.; Centre for Biodiscovery and Molecular Development of Therapeutics James Cook University Cairns QLD Australia., Hill MM; Precision and Systems Biomedicine Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia.; Centre for Clinical Research Faculty of Medicine The University of Queensland Brisbane QLD Australia., Lepletier A; Human Immunity Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia.; Laboratory of Vaccines for the Developing World Institute for Glycomics Southport QLD Australia.
Publikováno v: Clinical & translational immunology [Clin Transl Immunology] 2021 Sep 06; Vol. 10 (9), pp. e1334. Date of Electronic Publication: 2021 Sep 06 (Print Publication: 2021).
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje